These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
612 related articles for article (PubMed ID: 3876124)
21. The expression of the Hodgkin's disease-associated antigen Ki-1 in cutaneous infiltrates. van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA Acta Derm Venereol; 1988; 68(3):202-8. PubMed ID: 2455412 [TBL] [Abstract][Full Text] [Related]
22. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. van den Berg A; Visser L; Poppema S Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793 [TBL] [Abstract][Full Text] [Related]
23. High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients. Boiocchi M; De Re V; Gloghini A; Vaccher E; Dolcetti R; Marzotto A; Bertola G; Carbone A Int J Cancer; 1993 Apr; 54(1):53-9. PubMed ID: 8386709 [TBL] [Abstract][Full Text] [Related]
24. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Schwarting R; Gerdes J; Dürkop H; Falini B; Pileri S; Stein H Blood; 1989 Oct; 74(5):1678-89. PubMed ID: 2477085 [TBL] [Abstract][Full Text] [Related]
26. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study. Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619 [TBL] [Abstract][Full Text] [Related]
27. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Miettinen M Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642 [TBL] [Abstract][Full Text] [Related]
28. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies. Strauchen JA; Dimitriu-Bona A Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509 [TBL] [Abstract][Full Text] [Related]
29. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease. Hansmann ML; Fellbaum C; Hui PK; Lennert K Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946 [TBL] [Abstract][Full Text] [Related]
30. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [TBL] [Abstract][Full Text] [Related]
31. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553 [TBL] [Abstract][Full Text] [Related]
32. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Pinkus GS; Thomas P; Said JW Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932 [TBL] [Abstract][Full Text] [Related]
33. Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies. Ralfkiaer E; Stein H; Wantzin GL; Thomsen K; Ralfkiaer N; Mason DY Am J Clin Pathol; 1985 Nov; 84(5):587-93. PubMed ID: 3904400 [TBL] [Abstract][Full Text] [Related]
34. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells. Howard DR; Eaves AC; Takei F Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242 [TBL] [Abstract][Full Text] [Related]
35. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells. Imam A; Stathopoulos E; Taylor CR Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446 [TBL] [Abstract][Full Text] [Related]
36. Immunopathology of Hodgkin's disease. Strauchen JA Pathol Immunopathol Res; 1986; 5(3-5):253-64. PubMed ID: 3110753 [TBL] [Abstract][Full Text] [Related]
37. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification. Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694 [TBL] [Abstract][Full Text] [Related]
38. A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells. Nozawa Y; Wachi E; Tominaga K; Abe M; Wakasa H J Pathol; 1993 Mar; 169(3):309-15. PubMed ID: 8492223 [TBL] [Abstract][Full Text] [Related]
39. Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction. Ross CW; Schlegelmilch JA; Grogan TM; Weiss LM; Schnitzer B; Hanson CA Am J Pathol; 1992 Aug; 141(2):457-65. PubMed ID: 1323222 [TBL] [Abstract][Full Text] [Related]
40. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Wolf J; Kapp U; Bohlen H; Kornacker M; Schoch C; Stahl B; Mücke S; von Kalle C; Fonatsch C; Schaefer HE; Hansmann ML; Diehl V Blood; 1996 Apr; 87(8):3418-28. PubMed ID: 8605360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]